Zimmer Biomet reports increase in third-quarter net sales for 2021 compared with 2019
Click Here to Manage Email Alerts
Zimmer Biomet Holdings Inc. reported net sales of $1.924 billion for the third quarter of 2021, according to a press release.
The third-quarter net sales showed a 0.3% decrease from the same period in the prior year and a 0.8% decrease on a constant currency basis. However, third-quarter 2021 sales increased 1.7% compared with the pre-pandemic third quarter in 2019.
Zimmer Biomet earned a net of $145.6 million, or $381.2 million on an adjusted basis, in the third quarter of 2021. The company reported that diluted earnings per share were $0.69 and, when adjusted, diluted earnings per share were $1.81.
“Despite the continued challenges and market pressures in the third quarter, we drove significant progress in the advancement of our business priorities and continued focus on execution to create value and deliver on our mission," Bryan Hanson, chair, president and CEO of Zimmer Biomet, said in the release. "Our underlying business remains strong, fueled by our transformation and the launch of new innovative products that can make a difference for our customers and for patients. I continue to be incredibly proud of our team for their dedication, resilience and performance during this challenging time."
Read more about
Click Here to Manage Email Alerts